110 related articles for article (PubMed ID: 227926)
1. Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations.
Stobo JD; Kennedy MS; Goldyne ME
J Clin Invest; 1979 Nov; 64(5):1188-203. PubMed ID: 227926
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis.
Roper RL; Phipps RP
J Immunol; 1992 Nov; 149(9):2984-91. PubMed ID: 1328389
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E inhibition of T-lymphocyte colony formation: a possible mechanism of monocyte modulation of clonal expansion.
Bockman RS; Rothschild M
J Clin Invest; 1979 Sep; 64(3):812-9. PubMed ID: 313939
[TBL] [Abstract][Full Text] [Related]
5. Growth and protein phosphorylation in the Nb2 lymphoma: effect of prolactin, cAMP, and agents that activate adenylate cyclase.
Rayhel EJ; Hughes JP; Svihla DA; Prentice DA
J Cell Biochem; 1990 Aug; 43(4):327-37. PubMed ID: 2168897
[TBL] [Abstract][Full Text] [Related]
6. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M
Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585
[TBL] [Abstract][Full Text] [Related]
7. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
[TBL] [Abstract][Full Text] [Related]
8. Alveolar macrophages. VI. Regulation of alveolar macrophage-mediated suppression of lymphocyte proliferation by a putative T cell.
Warner LA; Holt PG; Mayrhofer G
Immunology; 1981 Jan; 42(1):137-47. PubMed ID: 6970172
[TBL] [Abstract][Full Text] [Related]
9. Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production.
Korn JH; Halushka PV; LeRoy EC
J Clin Invest; 1980 Feb; 65(2):543-54. PubMed ID: 7356693
[TBL] [Abstract][Full Text] [Related]
10. Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.
Papadogiannakis N; Johnsen SA; Olding LB
Clin Exp Immunol; 1985 Jul; 61(1):125-34. PubMed ID: 2931220
[TBL] [Abstract][Full Text] [Related]
11. Subpopulations of T lymphocytes from human blood differing in density and stage of maturation.
van de Griend RJ; Astaldi GC; van den Ende A; Loos JA; Roos D
Eur J Immunol; 1980 Jan; 10(1):70-3. PubMed ID: 6244964
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte function in human bone marrow. I. Characterization of two T cell populations regulating immunoglobulin secretion.
Mills GB; Ledgley CJ; Hibi T; White D; Lam P; Dosch HM
J Immunol; 1985 May; 134(5):3036-41. PubMed ID: 3156927
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
[TBL] [Abstract][Full Text] [Related]
14. On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C.
Refsnes M; Dajani OF; Sandnes D; Thoresen GH; Røttingen JA; Iversen JG; Christoffersen T
J Cell Physiol; 1995 Sep; 164(3):465-73. PubMed ID: 7650056
[TBL] [Abstract][Full Text] [Related]
15. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
16. The adenosine 3':5'-cyclic monophosphate response to prostaglandin E2 is altered in U937 cells in association with maturational events induced by activated T lymphocytes and 1,25-dihydroxyvitamin D3.
Goldring SR; Amento EP; Roelke MS; Krane SM
J Immunol; 1986 May; 136(9):3461-6. PubMed ID: 2420890
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis.
Roper RL; Conrad DH; Brown DM; Warner GL; Phipps RP
J Immunol; 1990 Oct; 145(8):2644-51. PubMed ID: 2170523
[TBL] [Abstract][Full Text] [Related]
18. The regulation of the immune response to polyvinylpyrollidone: antigen induced changes in prostaglandin and cyclic nucleotide levels.
Zimecki M; Webb DR; Rogers TJ
Arch Immunol Ther Exp (Warsz); 1980; 28(2):179-97. PubMed ID: 6255889
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of beta-adrenergic-induced cAMP accumulation in activated T-cells.
Carlson SL; Trauth K; Brooks WH; Roszman TL
J Cell Physiol; 1994 Oct; 161(1):39-48. PubMed ID: 7929606
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of the mitogenic and rosette-forming effects of PHA to stimulators of cyclic AMP levels.
Kalmár L; Gergely P; Petrányi G
Acta Med Acad Sci Hung; 1978; 35(2):147-51. PubMed ID: 217221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
